Isoacteoside, a naturally derived phenylethanoid glycoside, is emerging as a compound of significant interest in the field of cancer research due to its promising antitumor activities. The exploration of its Isoacteoside antitumor activity is revealing mechanisms by which it can potentially inhibit cancer cell proliferation and induce programmed cell death (apoptosis). This makes it a valuable subject for further investigation in the development of new cancer therapies.

Research has indicated that Isoacteoside can effectively induce apoptosis in various cancer cell lines, including OVCAR-3 cells. This process is critical for eliminating cancerous cells and preventing tumor growth. Furthermore, studies have shown that Isoacteoside can reduce tumor volume and weight in xenograft models, highlighting its potential as an antitumor agent. The precise Isoacteoside antitumor activity mechanism is still under investigation, but early findings point towards its role in modulating key cellular pathways involved in cell survival and death. NINGBO INNO PHARMCHEM CO.,LTD. provides high-quality Isoacteoside to facilitate this crucial research.


For researchers and pharmaceutical companies engaged in the development of novel cancer treatments, sourcing high-purity Isoacteoside is essential. As a reputable Isoacteoside supplier in China, we are dedicated to providing researchers with a reliable supply of this potent compound. The ability to buy Isoacteoside CAS 61303-13-7 from a trusted source like NINGBO INNO PHARMCHEM CO.,LTD. ensures the integrity and efficacy of your research experiments. The ongoing exploration of Isoacteoside's potential in oncology represents a significant advancement in the search for more effective cancer therapies.


The scientific community continues to uncover the multifaceted benefits of Isoacteoside. Its ability to selectively target cancer cells while potentially sparing healthy ones makes it an attractive candidate for further development. As research progresses, the role of Isoacteoside in combating various forms of cancer is becoming increasingly clear. We are committed to supporting these critical research efforts by providing a consistent supply of premium-quality Isoacteoside.